Literature DB >> 32785898

Hemodynamic changes in neonates born to mothers with Graves' disease.

Takamichi Ishikawa1, Hiroki Uchiyama2, Satoru Iwashima2, Toru Baba2, Akira Ohishi2, Shigeo Iijima2, Hiroaki Itoh3.   

Abstract

PURPOSE: Cardiac insufficiency is a major morbidity in neonatal hyperthyroidism. It is important to assess the hemodynamics in neonates born to mothers with Graves' disease (GD). This study prospectively evaluated the hemodynamic changes in neonates born to mothers with GD.
METHODS: Overall, 80 newborns were enrolled. Thirty-six neonates were born to mothers with GD who were positive for thyroid-stimulating hormone (TSH) receptor antibody (TRAb), and 44 were born to mother negative for TRAb. The serum levels of TSH, free triiodothyronine (FT3), free thyroxine (FT4), and N-terminal-pro-B-type natriuretic peptide (NT-proBNP), the cardiac output, and cardiac index (CI) evaluated by echocardiography were compared between the two groups at several postnatal points (day of delivery and 5, 10, and 30 days of life).
RESULTS: The TRAb-positive newborns had higher FT4 levels and CI on Day 5 (both p < 0.05) and higher FT3 (p < 0.05) and FT4 levels (p < 0.01) and CI (p < 0.01) but lower TSH levels (p < 0.05) on Day 10 than the TRAb-negative newborns. The TRAb-positive newborns had significantly higher NT-proBNP levels on Days 5 (median 752 vs. 563 pg/mL, p = 0.034) and 10 (median 789 vs. 552 pg/mL, p = 0.002) than the TRAb-negative newborns.
CONCLUSIONS: Hemodynamic changes in neonates born to TRAb-positive mothers with GD resulted in a higher CI and NT-proBNP levels than in those with TRAb-negative mothers from postnatal days 5 to 10.

Entities:  

Keywords:  Cardiac output; Echocardiography; N-terminal-pro-B-type natriuretic peptide; Neonatal hyperthyroidism; Thyroid-stimulating hormone receptor antibody

Year:  2020        PMID: 32785898     DOI: 10.1007/s12020-020-02443-w

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  34 in total

Review 1.  Fetal and neonatal hyperthyroidism.

Authors:  D Zimmerman
Journal:  Thyroid       Date:  1999-07       Impact factor: 6.568

Review 2.  Fetal and neonatal hyperthyroidism and hypothyroidism due to maternal TSH receptor antibodies.

Authors:  J M McKenzie; M Zakarija
Journal:  Thyroid       Date:  1992       Impact factor: 6.568

3.  Survival time of circulating long-acting thyroid stimulator in neonatal thyrotoxicosis: implications for diagnosis and therapy of the disorder.

Authors:  P Sunshine; H Kusumoto; J P Kriss
Journal:  Pediatrics       Date:  1965-12       Impact factor: 7.124

4.  Neonatal thyrotoxicosis associated with the hyperviscosity syndrome.

Authors:  Y L Bussmann; M L Tillman; A S Pagliara
Journal:  J Pediatr       Date:  1977-02       Impact factor: 4.406

5.  Reversible pulmonary hypertension in neonatal Graves disease.

Authors:  D O'Donovan; C McMahon; C Costigan; P Oslizlok; D Duff
Journal:  Ir Med J       Date:  1997 Jun-Jul

Review 6.  Foetal and neonatal thyroid disorders.

Authors:  G Radetti; A Zavallone; L Gentili; P Beck-Peccoz; G Bona
Journal:  Minerva Pediatr       Date:  2002-10       Impact factor: 1.312

7.  Neonatal hyperthyroidism and heart failure. A differential approach.

Authors:  E S Lightner; H D Allen; G Loughlin
Journal:  Am J Dis Child       Date:  1977-01

Review 8.  Management of Graves' hyperthyroidism in pregnancy: focus on both maternal and foetal thyroid function, and caution against surgical thyroidectomy in pregnancy.

Authors:  Peter Laurberg; Claire Bournaud; Jesper Karmisholt; Jacques Orgiazzi
Journal:  Eur J Endocrinol       Date:  2008-10-10       Impact factor: 6.664

9.  Neonatal hyperthyroidism: neonatal clinical course of two brothers born to a mother with Graves-Basedow disease, before and after total thyroidectomy.

Authors:  A A Zuppa; P Sindico; I Savarese; V D'Andrea; A Fracchiolla; F Cota; C Romagnoli
Journal:  J Pediatr Endocrinol Metab       Date:  2007-04       Impact factor: 1.634

Review 10.  Hyperthyroidism in early infancy: pathogenesis, clinical features and diagnosis with a focus on neonatal hyperthyroidism.

Authors:  M Polak
Journal:  Thyroid       Date:  1998-12       Impact factor: 6.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.